REQUEST A DEMO
Total
USD $0.00
Search more companies

Reimex Pharma Ltd OOD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Reimex Pharma Ltd OOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Reimex Pharma Ltd OOD is a company in Bulgaria, with a head office in Sofia. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Reimex Pharma Ltd OOD was incorporated on 2022. 11 (2023) employees currently work for Reimex Pharma Ltd OOD. In 2022, the company reported a net sales revenue increase of 185.83%. Its’ total assets recorded a growth of 130.59%. Reimex Pharma Ltd OOD’s net profit margin decreased by 0.21% in 2022.

Headquarters
Sq.Ovdivsko Pole No 11, Office 22 Str., Darvenitsa Distr.
Sofia; Sofia - city; Postal Code: 1756

Contact Details: Purchase the Reimex Pharma Ltd OOD report to view the information.

Basic Information
Total Employees:
Purchase the Reimex Pharma Ltd OOD report to view the information.
Outstanding Shares:
Purchase the Reimex Pharma Ltd OOD report to view the information.
Registered Capital:
Purchase the Reimex Pharma Ltd OOD report to view the information.
Incorporation Date:
2022
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Reimex Pharma Ltd OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
185.83%
Total operating revenue
185.86%
Net Profit (Loss) for the Period
181.5%
Total assets
130.59%
Total equity
173.21%
Net Profit Margin
-0.21%
Return on Equity (ROE)
2.54%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?